Preventive Healthcare Technologies, Products and Markets

Preventive Healthcare Technologies, Products and Markets published by BCC Research in October, 2009. This report consists of 157 pages and the price starts from US $ 4850.

Introduction

Abstract

• Forecasts for the U.S. market in products and services, providing data for 2008 and estimates for 2009, and projections for the market and compound annual growth rates (CAGRs) from 2009 to 2014, and 2014 to 2019
• An overview of preventive healthcare functions, including early detection, prophylaxis, prevention of errors in therapy, and chronic care management
• A breakdown of the market for early detection and screening products, including prenatal and neonatal tests, pediatric tests, and adult tests for both sexes
• Detailed company profiles and a patent analysis.

SCOPE OF REPORT

At the broadest level, preventive healthcare includes everything from over-the-counter (OTC) products designed to help users curb smoking or overeating to advanced genetic testing to identify a predisposition to certain cancers or other health problems. However, the scope of this report is limited to products that are available only by prescription, and related professional services that: Provide early warning of a disease before it becomes symptomatic. Identify a predisposition to disease or other health problem, so that appropriate steps can be taken (e.g., genetic screening for various cancers). Protect against or strengthen the body' s resistance to disease (e.g., vaccines). Reduce the possibility of unintended adverse impacts from therapy (e.g., adverse drug reactions). Are used in the management of chronic medical conditions. Some of these technologies, such as certain vaccines, are decades old, while others (e.g., cytomics) are still largely at the experimental stage for clinical applications. This report generally focuses on new or emerging technologies, without being too rigid about what constitutes a “new” technology. Technologies of particular interest include genomics, proteomics, cytomics, radiology, nanotechnology, informatics and automation.

The primary focus of the report is on the U.S. market for preventive healthcare technologies and services. However, it also includes a section that highlights major features of the international market for these technologies.

• Summary
• Definitions
• Types of preventive healthcare technologies and services and their main applications
• Enabling technologies
• End-user segments
• Market environment (legal and regulatory, standards, trends in the healthcare industry, demographic and economic trends, other market drivers and barriers to deployment)
• Detailed market estimates and projections for each preventive healthcare technology or service during the period 2008 - 2014
• Supplier profiles
• Patent analysis.

METHODOLOGY

Both primary and secondary research methodologies were used in conducting this market research. The findings and conclusions of this report are based on information gathered from developers, vendors, integrators and users of preventive healthcare technologies and services. Interview data were combined with information gathered through an extensive review of secondary sources, such as trade publications, trade associations, company literature, and online databases, to produce the baseline market estimates contained in this report.

The base year for analysis and projection is 2008. With 2008 as a baseline, market projections were developed for 2009 to 2014. The projections are based on a combination of a consensus among the primary contacts combined with BCC' s understanding of the key market drivers and their impact from a historical and analytical perspective. The specific assumptions and approach BCC used to develop the projections (near and mid-term, and long term) for each application is documented in detail under the various segments addressed. This way, readers can see how the market estimates were developed and, if they so desire, test the impact on the final numbers of changing assumptions regarding such matters as date of regulatory approval. All dollar projections presented in this report are in 2008 constant dollars, and represent market value at the manufacturer level.

AUTHOR' S CREDENTIALS

The author of this report is Andrew McWilliams. Mr. McWilliams, a partner in the Boston-based international technology and marketing consulting firm of 43rd Parallel LLC, is the author of several other BCC Research studies of the healthcare and related industries, including: HLC016C Microelectronic Medical Implants: Products, Technologies & Opportunities, HLC036C Medical Robotics and Computer-Assisted Surgery, HLC051D Trends in the Noninvasive and Minimally Invasive Medical Device Market, HLC038B Patient Monitoring, HLC054A The Home Medical Equipment Market, HLC048B Healthcare Information Technology and HLC066A Medical Automation Technologies, Products and Markets.

Table of Contents

Preventive Healthcare Technologies, Products and Markets

Chapter- 1: INTRODUCTION -- Complimentary

• STUDY BACKGROUND
• GOALS AND OBJECTIVES
• INTENDED AUDIENCE
• SCOPE OF REPORT
• METHODOLOGY
• AUTHOR' S CREDENTIALS
• RELATED BCC REPORTS
• BCC ONLINE SERVICES
• DISCLAIMER

Chapter-2: SUMMARY

• SUMMARY TABLE U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES AND SERVICES, THROUGH 2014 ($ MILLIONS)
• SUMMARY FIGURE U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES AND SERVICES, 2008-2014 ($ MILLIONS)

Chapter-3: OVERVIEW OF PREVENTIVE HEALTHCARE

• DEFINITIONS
• PREVENTIVE HEALTHCARE FUNCTIONS
• EARLY DETECTION
  • TABLE 1 U.S. AGENCY FOR HEALTHCARE RESEARCH AND QUALITY RECOMMENDED SCREENING PROCEDURES
• Personalized Screening
• Automated Screening
• Other New Screening Technologies
• PROPHYLAXIS
• PREVENTION OF ERRORS, ADVERSE EFFECTS, AND COMPLICATIONS FROM MEDICAL TREATMENT
• CHRONIC DISEASE MANAGEMENT
• ENABLING TECHNOLOGIES
• GENOMICS/PROTEOMICS/CYTOMICS
• Genomics
• Genomics (Continued)
• Proteomics
• Cytomics
• NANOTECHNOLOGY
• Nanomaterials
• Nanodevices
• INFORMATION TECHNOLOGIES
• Electronic Prescribing Systems
• Clinical Decision Support Systems
• AUTOMATION
• Wireless Technologies
• Sensors
• Robotics
• Artificial Intelligence and Decision Support
  • TABLE 2 APPLICATIONS OF ARTIFICIAL INTELLIGENCE TO PREVENTIVE HEALTHCARE
• RFID/Barcoding
• END USER SEGMENTS
• HOSPITALS
• PHYSICIAN PRACTICES
• LONG-TERM CARE FACILITIES
• MILITARY
• HEALTH INSURERS
• EMPLOYERS
• CONSUMERS
  • FIGURE 1 PROJECTED U.S. POPULATION, 2008 - 2019 (MILLIONS)
• Persons Requiring Screening and Early Detection Services
• Persons Requiring Prophylaxis
  • TABLE 3 TARGET GROUPS FOR SELECTED VACCINES, 2008 (MILLIONS)
• Persons with Chronic Illness
• Hypertension
• Diabetes
• High Cholesterol Levels
• Heart Disease
• Asthma
• MARKET SUMMARY
  • TABLE 4 U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES AND SERVICES BY FUNCTION, THROUGH 2014 ($ MILLIONS)
  • FIGURE 2 U.S. MARKET FOR NEW PREVENTIVE HEALTHCARE TECHNOLOGIES MARKET SHARES BY FUNCTION, 2008 - 2014 (%)

Chapter-4: MARKET ENVIRONMENT FOR PREVENTIVE HEALTHCARE

• FEDERAL GOVERNMENT INITIATIVES
• CENTERS FOR MEDICARE AND MEDICAID SERVICES
• Medicare
• Medicaid
• SCHIP
• OTHER FEDERAL PREVENTIVE-CARE PROGRAMS
• Immunization Grant (Section 317) Program
• National Breast and Cervical Cancer Early Detection Program
• PROPOSED U.S. HEALTHCARE SYSTEM RESTRUCTURING
• RELATED FEDERAL INITIATIVES
• ETHICAL CONCERNS

Chapter-5: TRENDS IN THE HEALTHCARE INDUSTRY

• RISING HEALTHCARE COSTS
  • FIGURE 3 TOTAL U.S. HEALTHCARE EXPENDITURES, 1968 - 2008 ($ BILLIONS IN 2008 DOLLARS)
  • FIGURE 4 PER-CAPITA U.S. HEALTHCARE EXPENDITURES, 1968 - 2008 ($ BILLIONS IN 2008 DOLLARS)
  • FIGURE 5 U.S. HEALTHCARE EXPENDITURES AS A PERCENTAGE OF REAL GDP, 1968 AND 2008 (2008 $ BILLIONS)
• PREVENTIVE HEALTHCARE AND OVERALL MEDICAL EXPENDITURES
  • FIGURE 6 U.S. EXPENDITURES ON PREVENTIVE VS. OTHER TYPES OF HEALTHCARE, 2008 ($ BILLIONS)
• PREVENTIVE HEALTHCARE ... (CONTINUED)
• HEALTH INSURANCE COVERAGE AND REIMBURSEMENT
• MEDICAL EDUCATION
• HEALTHCARE PROFESSIONALS' ATTITUDES
• PATIENT ATTITUDES
• ECONOMIC ENVIRONMENT
• EMPLOYMENT TRENDS
  • FIGURE 7 TRENDS IN U.S. NON-FARM PAYROLL EMPLOYMENT (000 WORKERS)
• IMPACT OF ECONOMIC TRENDS ON EMPLOYER HEALTH COVERAGE
  • FIGURE 8 TRENDS IN EMPLOYER-SPONSORED HEALTH INSURANCE, 2000 - 2008 (PERCENT OF U.S. COMPANIES OFFERING HEALTH INSURANCE)
  • FIGURE 8 (CONTINUED)

Chapter-6: EARLY DETECTION AND SCREENING: TECHNOLOGIES, PRODUCTS AND MARKETS, 2008-2014

• SUMMARY
  • FIGURE 9 U.S. MARKET FOR ADVANCED HEALTH SCREENING AND EARLY DETECTON TECHNOLOGIES, 2008 - 2014 ($ MILLIONS)
• TECHNOLOGIES AND PRODUCTS
• PERSONALIZED MEDICINE
• Genetic Testing
• Genetic Testing (Continued)
• Suppliers of Genetic Tests
  • TABLE 5 SUPPLIERS OF GENETIC TESTS
• Proteomic Tests
• Proteomic Tests (Continued)
• Suppliers of Proteomic Tests
  • TABLE 6 SUPPLIERS OF PROTEOMIC TESTS
• AUTOMATED SCREENING
• Telehealth Kiosks
• Telehealth Kiosks (Continued)
• Suppliers of Telehealth Kiosks
  • TABLE 7 SUPPLIERS OF TELEHEALTH KIOSKS
• Eye Health Kiosks
• Automated Drug Testing
• Suppliers of Automated Drug Testing Equipment
  • TABLE 8 DEVELOPERS AND SUPPLIERS OF AUTOMATED DRUG TESTING EQUIPMENT
• OTHER ADVANCED SCREENING TESTS
• Breast Cancer Screening
• Molecular Breast Imaging
• Automated Whole Breast Ultrasound
• CT Colonography
• Automated Skin Cancer Screening
• Suppliers
  • TABLE 9 DEVELOPERS AND SUPPLIERS OF OTHER ADVANCED HEALTH SCREENING TECHNOLOGIES
• MARKETS
• SUMMARY
  • TABLE 10 U.S. MARKET FOR ADVANCED HEALTH SCREENING AND EARLY DETECTION TECHNOLOGIES, THROUGH 2014 ($ MILLIONS)
  • FIGURE 10 EARLY DETECTION AND SCREENING PRODUCT SEGMENTS, 2008-2014 (%)
  • FIGURE 10 (CONTINUED)
• PERSONALIZED MEDICINE
  • TABLE 11 U.S. MARKET FOR PERSONALIZED PREVENTIVE MEDICINE ($ MILLIONS)
• Genetic Screening
  • FIGURE 11 U.S. GENETIC TESTING MARKET SHARES, 2008 (%)
  • TABLE 12 U.S. MARKET FOR GENETIC SCREENING TESTS ($ MILLIONS)
• Proteomic Screening
  • TABLE 13 U.S. MARKET FOR PROTEOMIC SCREENING TESTS ($ MILLIONS)
• AUTOMATED SCREENING
  • TABLE 14 U.S. MARKET FOR AUTOMATED HEALTH ASSESSMENT AND SCREENING SYSTEMS BY TYPE OF SYSTEM, THROUGH 2014 ($ MILLIONS)
• Telehealth Kiosks
  • TABLE 15 NEW TELEHEALTH KIOSK SALES AND LEASE REVENUES, 2014 (UNITS/$)
• Eye Health Kiosks
  • TABLE 16 U.S. MARKET FOR AUTOMATED EYE HEALTH KIOSKS, THROUGH 2014 ($ MILLIONS)
• Automated Drug Testing
  • FIGURE 12 AUTOMATED TEST EQUIPMENT SHARE OF DRUG TESTING MARKET, 2008 (%)
  • FIGURE 13 DRUGS OF ABUSE VS. THERAPEUTIC DRUG TESTING SHARES OF AUTOMATED DRUG TESTING EQUIPMENT MARKET, 2008 (%)
  • TABLE 17 U.S. MARKET FOR AUTOMATED DRUG TESTING SYSTEMS, THROUGH 2014 ($ MILLIONS)
• OTHER ADVANCED SCREENING AND EARLY DETECTION TECHNOLOGIES
  • TABLE 18 U.S. MARKET FOR OTHER ADVANCED SCREENING TECHNOLOGIES BY TYPE OF SYSTEM, THROUGH 2014 ($ MILLIONS)
• BREAST CANCER SCREENING
  • TABLE 19 U.S. MARKET FOR ADVANCED BREAST CANCER SCREENING SYSTEMS, THROUGH 2014 ($ MILLIONS)
• Molecular Breast Imaging
  • TABLE 20 U.S. MARKET FOR MOLECULAR BREAST IMAGING SYSTEMS, THROUGH 2014 ($ MILLIONS)
• ABUS
  • TABLE 21 U.S. MARKET FOR AUTOMATED WHOLE BREAST ULTRASOUND SYSTEMS, THROUGH 2014 ($ MILLIONS)
• CT COLONOGRAPHY
  • TABLE 22 U.S. MARKET FOR CT COLONOGRAPHY, THROUGH 2014 ($ MILLIONS)
• AUTOMATED SKIN CANCER DETECTION
  • TABLE 23 U.S. MARKET FOR AUTOMATED SKIN CANCER DETECTION SYSTEMS, THROUGH 2014 ($ MILLIONS)

Chapter-7: PROPHYLAXIS: TECHNOLOGIES, PRODUCTS AND MARKETS

• SUMMARY
  • FIGURE 14 U.S. MARKET FOR NEW VACCINES, 2008 - 2014 ($ MILLIONS)
• TECHNOLOGIES
• FLU VACCINES
• Bird Flu Vaccine
• Swine Flu Vaccine
• MENINGOCOCCAL VACCINES
• COMBINED TETANUS-DIPHTHERIA-PERTUSSIS VACCINES
• HUMAN PAPILLOMA VIRUS VACCINE
• OTHER NEW VACCINES
• MMR/Varicella Vaccine
• Rotavirus Vaccines
• Shingles Vaccine
• MARKETS
• SUMMARY
  • FIGURE 15 U.S. MARKET FOR NEW HUMAN VACCINES, 2008 (%)
  • FIGURE 15 (CONTINUED)
  • TABLE 24 U.S. MARKET FOR NEW VACCINES, THROUGH 2014 ($ MILLIONS)
• FLU VACCINES
  • TABLE 25 U.S. PURCHASES OF NOVEL FLU VACCINES, THROUGH 2014 ($ MILLIONS)
• MENINGOCOCCAL VACCINES
  • TABLE 26 U.S. MARKET FOR MENINGOCOCCAL VACCINES, THROUGH 2014 ($ MILLIONS)
• TDAP VACCINES
  • TABLE 27 U.S. MARKET FOR TDAP VACCINES, THROUGH 2014 ($ MILLIONS)
• HPV VACCINES
  • TABLE 28 U.S. MARKET FOR HPV VACCINES, THROUGH 2014 ($ MILLIONS)
• OTHER NEW VACCINES
• MMR/Varicella
  • TABLE 29 U.S. MARKET FOR OTHER NEW VACCINES, THROUGH 2014 ($ MILLIONS)
• Rotavirus
• Shingles

Chapter-8: PREVENTING THERAPEUTIC ERRORS AND FAILURES: TECHNOLOGIES, PRODUCTS AND MARKETS

• SUMMARY
  • FIGURE 16 U.S. MARKET FOR THERAPEUTIC ERROR AVOIDANCE TECHNOLOGIES PROJECT SHARES, 2008 - 2014 ($ MILLIONS)
• TECHNOLOGIES
• CLINICAL DECISION AIDS AND OTHER INFORMATION TECHNOLOGIES
• Electronic Prescribing
• Software
• Software (Continued)
• Software (Continued)
• Mobile Interface Devices
• Electronic Data Interchange
  • TABLE 30 E-PRESCRIPTION SOFTWARE VENDORS
• Computerized Provider Order Entry Systems
• Computerized Provider ... (Continued)
  • TABLE 31 CPOE TECHNOLOGY VENDORS
• Clinical Decision Support Systems
  • TABLE 32 CLINICAL DECISION SUPPORT TECHNOLOGY VENDORS
• MEDICATION FORMULATION, DISPENSING, AND PACKAGING SYSTEMS
• Automated Prescription Formulation/Dispensing Systems
• Packaging Machines
• Tablet Counters
• Unit-Dose or Blister Pack Repackaging and Dispensing Systems
• Intravenous Compounders
• Dispensing Systems
• Centralized Dispensing Systems
• Automated Medication Carts
• Decentralized Dispensing Dev ices
• Smart Infusion Pumps
  • TABLE 33 SUPPLIERS OF AUTOMATED PRESCRIPTION FORMULATION AND DISPENSING SYSTEMS
• Packaging
• Bottle Cap Medication Reminder
• Medication Label Reader for the Visually Impaired
• MARKETS
• SUMMARY
  • TABLE 34 U.S. MARKET FOR THERAPEUTIC ERROR AVOIDANCE TECHNOLOGIES, THROUGH 2014 ($ MILLIONS)
  • FIGURE 17 THERAPEUTIC ERROR AVOIDANCE TECHNOLOGIES PROJECT SHARES, 2008 - 2014 (%)
• ELECTRONIC PRESCRIBING
  • TABLE 35 U.S. MARKET FOR ELECTRONIC PRESCRIBING TECHNOLOGIES, THROUGH 2014 ($ MILLIONS)
  • FIGURE 18 U.S. ELECTRONIC PRESCRIPTION MARKET SEGMENTS (%)
• COMPUTERIZED PROVIDER ORDER ENTRY
  • TABLE 36 NUMBER OF U.S. HOSPITALS WITH COMPUTERIZED PROVIDER ORDER ENTRY SYSTEMS, THROUGH 2007
  • TABLE 37 U.S. MARKET FOR COMPUTERIZED PROVIDER ORDER ENTRY SYSTEMS, THROUGH 2014 ($ MILLIONS)
• COMPUTERIZED DECISION SUPPORT
  • TABLE 38 U.S. MARKET FOR CLINICAL DECISION SUPPORT SYSTEMS, THROUGH 2014 ($ MILLIONS)
• AUTOMATED PRESCRIPTION FORMULATION AND DISPENSING
  • TABLE 39 U.S. MARKET FOR HOSPITAL/INPATIENT AUTOMATED PRESCRIPTION FORMULATION AND DISPENSING SYSTEMS, THROUGH 2014 ($ MILLIONS)
• SMART INFUSION PUMPS
  • TABLE 40 U.S. MARKET FOR SMART INFUSION PUMPS, THROUGH 2014 ($ MILLIONS)
• SMART PACKAGING
  • TABLE 41 U.S. MARKET FOR SMART PACKAGING TO PREVENT MEDICATION ERRORS, THROUGH 2014 ($ MILLIONS)
• Smart Packaging (Continued)

Chapter-9: CHRONIC DISEASE MANAGEMENT: TECHNOLOGIES, PRODUCTS AND MARKETS

• SUMMARY
  • FIGURE 19 U.S. MARKET FOR ADVANCED CHRONIC DISEASE MANAGEMENT TECHNOLOGIES AND SERVICES, 2008-2014 ($ MILLIONS)
• TECHNOLOGIES
• MONITORING
• Blood Pressure Monitors
• Blood Pressure Monitors (Continued)
• Glucose Monitors
• Glucose Monitors (Continued)
• Cholesterol Monitors
• Cardiac Monitors
• Asthma Monitors
• Pervasive Monitoring
• Embedded Monitors
• Wearable Monitors
• Wireless Telemetry
• Cellular Networks
• Bluetooth
• Other Technologies
• Suppliers
  • TABLE 42 SUPPLIERS OF ADVANCED TECHNOLOGIES FOR MONITORING CHRONIC DISEASES
• THERAPEUTIC DEVICES
• Insulin Administration Devices
• Insulin Pumps
• Insulin Inhalers
• Suppliers
  • TABLE 43 SUPPLIERS OF ADVANCED THERAPEUTIC DEVICES FOR CHRONIC DISEASES
• COMMERCIAL CHRONIC DISEASE MANAGEMENT SERVICES
• Commercial Chronic Disease ... (Continued)
• Suppliers
  • TABLE 44 CHRONIC DISEASE MANAGEMENT ORGANIZATIONS
• MARKETS
• SUMMARY
  • TABLE 45 MARKET FOR CHRONIC DISEASE MANAGEMENT TECHNOLOGIES, THROUGH 2014 ($ MILLIONS)
  • FIGURE 20 CHRONIC DISEASE MANAGEMENT TECHNOLOGIES AND SERVICES MARKET SHARES, 2008-2014 (%)
  • FIGURE 20 (CONTINUED)
• MONITORING
  • TABLE 46 MARKET FOR ADVANCED MONITORING TECHNOLOGIES FOR CHRONIC DISEASE MANAGEMENT, THROUGH 2014 ($ MILLIONS)
• Advanced Sensors
  • TABLE 47 U.S. MARKET FOR ADVANCED NONINVASIVE SENSORS, THROUGH 2014 ($ MILLIONS)
• Pervasive Monitoring
  • TABLE 48 HOME MONITORING AND TELEMETRY SALES, THROUGH 2014 ($ MILLIONS)
• Telemetry
  • TABLE 49 SALES OF HOME TELEMETRY MONITORS, THROUGH 2014 ($ MILLIONS)
• THERAPEUTIC DEVICES
  • TABLE 50 MARKET FOR ADVANCED THERAPEUTIC DEVICES FOR CHRONIC DISEASE MANAGEMENT, THROUGH 2014 ($ MILLIONS)
• Insulin Pumps
  • TABLE 51 MARKET FOR INSULIN PUMPS, THROUGH 2014 ($ MILLIONS)
  • TABLE 52 INSULIN PUMP SALES, THROUGH 2014 (NUMBER OF PUMPS/$ MILLION)
• Insulin Inhalers
  • TABLE 53 MARKET FOR INSULIN INHALERS, THROUGH 2014 ($ MILLIONS)
• DISEASE MANAGEMENT SERVICES
  • TABLE 54 MARKET FOR COMMERCIAL DM SERVICES, THROUGH 2014 ($ MILLIONS)

Chapter-10: APPENDIX

• APPENDIX A: COMPANY PROFILES
• EARLY DETECTION AND SCREENING
• COMPUTERIZED SCREENING INC.
• CORRELOGIC SYSTEMS, INC.
• DILON TECHNOLOGIES
• GAMMA MEDICA-IDEAS, INC.
• ICAD INC.
• MYRIAD GENETICS, INC.
• NOVX SYSTEMS INC.
• POLARTECHNICS LTD.
• STREETIME TECHNOLOGIES
• U-SYSTEMS, INC.
• VERMILLION, INC.
• VIATRONIX, INC.
• PROPHYLAXIS
• MERCK & CO., INC.
• ERROR PREVENTION
• BAXA CORP.
• DRFIRST.COM
• LIFECOM, INC.
• MASSACHUSETTS GENERAL HOSPITAL
• OMNICELL, INC.
• SCRIPTPRO
• SIGMA INTERNATIONAL GENERAL MEDICAL APPARATUS LLC
• SURESCRIPTS LLC
• THERADOC INC.
• CHRONIC DISEASE MANAGEMENT
• ALERE
• CARD GUARD AG
• ECHO THERAPEUTICS, INC.
• HEALTH FRONTIER, INC.
• HEALTHWAYS, INC.
• MANNKIND CORP.
• MEDTRONIC MINIMED INC.
• MICRODOSE THERAPEUTX, INC.
• OMRON HEALTHCARE, INC.
• PFIZER INC.
• PREMD INC.
• T+ MEDICAL AMERICAS
• U.S. PREVENTIVE MEDICINE
• VECTURA GROUP PLC
• VIVOMETRICS INC.
• APPENDIX B: PATENT ANALYSIS
  • FIGURE 21 U.S. PATENTS RELATED TO NEW PREVENTIVE HEALTHCARE TECHNOLOGIES (%)

Related Reports